Literature DB >> 26628377

Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors.

Supreet Agarwal1, Paul G Hynes1, Heather S Tillman1, Ross Lake1, Wassim G Abou-Kheir1, Lei Fang1, Orla M Casey1, Amir H Ameri1, Philip L Martin2, Juan Juan Yin1, Phillip J Iaquinta3, Wouter R Karthaus3, Hans C Clevers4, Charles L Sawyers5, Kathleen Kelly6.   

Abstract

Primary prostate cancer almost always has a luminal phenotype. However, little is known about the stem/progenitor properties of transformed cells within tumors. Using the aggressive Pten/Tp53-null mouse model of prostate cancer, we show that two classes of luminal progenitors exist within a tumor. Not only did tumors contain previously described multipotent progenitors, but also a major population of committed luminal progenitors. Luminal cells, sorted directly from tumors or grown as organoids, initiated tumors of adenocarcinoma or multilineage histological phenotypes, which is consistent with luminal and multipotent differentiation potentials, respectively. Moreover, using organoids we show that the ability of luminal-committed progenitors to self-renew is a tumor-specific property, absent in benign luminal cells. Finally, a significant fraction of luminal progenitors survived in vivo castration. In all, these data reveal two luminal tumor populations with different stem/progenitor cell capacities, providing insight into prostate cancer cells that initiate tumors and can influence treatment response.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  castration; heterogeneity; luminal; prostate cancer; stem/progenitor cells

Mesh:

Year:  2015        PMID: 26628377      PMCID: PMC4840850          DOI: 10.1016/j.celrep.2015.10.077

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  43 in total

1.  Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.

Authors:  Shunyou Wang; Alejandro J Garcia; Michelle Wu; Devon A Lawson; Owen N Witte; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia.

Authors:  Jean-Christophe Pignon; Chiara Grisanzio; Yan Geng; Jiaxi Song; Ramesh A Shivdasani; Sabina Signoretti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-25       Impact factor: 11.205

Review 3.  The roots of cancer: stem cells and the basis for tumor heterogeneity.

Authors:  Maho Shibata; Michael M Shen
Journal:  Bioessays       Date:  2012-10-02       Impact factor: 4.345

Review 4.  Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration.

Authors:  Cédric Blanpain; Elaine Fuchs
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

5.  Identification of multipotent luminal progenitor cells in human prostate organoid cultures.

Authors:  Wouter R Karthaus; Phillip J Iaquinta; Jarno Drost; Ana Gracanin; Ruben van Boxtel; John Wongvipat; Catherine M Dowling; Dong Gao; Harry Begthel; Norman Sachs; Robert G J Vries; Edwin Cuppen; Yu Chen; Charles L Sawyers; Hans C Clevers
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

6.  Organoid cultures derived from patients with advanced prostate cancer.

Authors:  Dong Gao; Ian Vela; Andrea Sboner; Phillip J Iaquinta; Wouter R Karthaus; Anuradha Gopalan; Catherine Dowling; Jackline N Wanjala; Eva A Undvall; Vivek K Arora; John Wongvipat; Myriam Kossai; Sinan Ramazanoglu; Luendreo P Barboza; Wei Di; Zhen Cao; Qi Fan Zhang; Inna Sirota; Leili Ran; Theresa Y MacDonald; Himisha Beltran; Juan-Miguel Mosquera; Karim A Touijer; Peter T Scardino; Vincent P Laudone; Kristen R Curtis; Dana E Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Stephen B Solomon; James A Eastham; Ping Chi; Brett Carver; Mark A Rubin; Howard I Scher; Hans Clevers; Charles L Sawyers; Yu Chen
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

7.  A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.

Authors:  Roxanne Toivanen; Mark Frydenberg; Declan Murphy; John Pedersen; Andrew Ryan; David Pook; David M Berman; Renea A Taylor; Gail P Risbridger
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

8.  Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.

Authors:  Zhu A Wang; Antonina Mitrofanova; Sarah K Bergren; Cory Abate-Shen; Robert D Cardiff; Andrea Califano; Michael M Shen
Journal:  Nat Cell Biol       Date:  2013-02-24       Impact factor: 28.824

9.  The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice.

Authors:  Dong-Kee Lee; Yonghong Liu; Lan Liao; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-09-06       Impact factor: 6.580

10.  Single luminal epithelial progenitors can generate prostate organoids in culture.

Authors:  Chee Wai Chua; Maho Shibata; Ming Lei; Roxanne Toivanen; LaMont J Barlow; Sarah K Bergren; Ketan K Badani; James M McKiernan; Mitchell C Benson; Hanina Hibshoosh; Michael M Shen
Journal:  Nat Cell Biol       Date:  2014-09-21       Impact factor: 28.824

View more
  25 in total

1.  Strategies to Identify and Target Cells of Origin in Prostate Cancer.

Authors:  Wouter R Karthaus; Charles L Sawyers
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

Review 2.  The potential of organoids in urological cancer research.

Authors:  Shangqian Wang; Dong Gao; Yu Chen
Journal:  Nat Rev Urol       Date:  2017-05-23       Impact factor: 14.432

Review 3.  Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma.

Authors:  Sara Laudato; Ana Aparicio; Filippo G Giancotti
Journal:  Trends Cancer       Date:  2019-06-29

4.  Gambogic Acid Induces Cell Apoptosis and Inhibits MAPK Pathway in PTEN-/-/p53-/- Prostate Cancer Cells In Vitro and Ex Vivo.

Authors:  Hong Pan; Li-Yuan Lu; Xue-Qian Wang; Bin-Xue Li; Kathleen Kelly; Hong-Sheng Lin
Journal:  Chin J Integr Med       Date:  2017-06-03       Impact factor: 1.978

Review 5.  Prostate luminal progenitor cells: from mouse to human, from health to disease.

Authors:  Manon Baures; Charles Dariane; Elisavet Tika; Emilia Puig Lombardi; Nicolas Barry Delongchamps; Cedric Blanpain; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Nat Rev Urol       Date:  2022-01-25       Impact factor: 14.432

Review 6.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01

Review 7.  Prostate Stem Cells and Cancer Stem Cells.

Authors:  Jia J Li; Michael M Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915

8.  Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer.

Authors:  Kristine M Wadosky; Yanqing Wang; Xiaojing Zhang; David W Goodrich
Journal:  J Vis Exp       Date:  2019-06-13       Impact factor: 1.424

Review 9.  Zebrafish Xenografts for Drug Discovery and Personalized Medicine.

Authors:  Jerry Xiao; Eric Glasgow; Seema Agarwal
Journal:  Trends Cancer       Date:  2020-04-17

Review 10.  Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models.

Authors:  Weiping Li; Michael M Shen
Journal:  Semin Cancer Biol       Date:  2021-06-18       Impact factor: 17.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.